Novo Nordisk's senior management shake-up continues, with Greater China President Zhou Xaping resigning, and veteran Cai Yan taking over.

K-LinePoet · 2026-01-30T21:15:01+00:00

Novo Nordisk announces that Zhou Xaping, Senior Vice President and President of Greater China, will leave the company on March 31, 2026, and Cai Yan will succeed her on March 1. Cai Yan has worked at Novo Nordisk for over 23 years and has experience in multiple executive development programs.

K-LinePoet

2026-01-30 21:15:01

Abstract generation in progress

On January 30, Times Finance learned from Novo Nordisk that Zhou Xaping, Senior Vice President and President of Greater China at Novo Nordisk, will resign, with her last working day being March 31, 2026. The new Senior Vice President and President of Greater China will be Cai Yan, and the personnel change will take effect on March 1, 2023.

According to Novo Nordisk, Cai Yan graduated from Sun Yat-sen University of Medical Sciences in China and earned a Ph.D. from the University of Copenhagen. She has also completed several executive development programs, including at Harvard Business School, and serves on the board of the World Diabetes Foundation (WDF). She has been with Novo Nordisk for over 23 years, holding several key positions in R&D headquarters and the International Operations (IO) department. (Times Finance Zhang Yuqi)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.